Therapeutic Efficiency of Mandibular Advancement Device Using Smartphone Sleep Applications and Pulse Oximeter
Therapeutic Efficiency of Mandibular Advancement Device Using Smartphone Sleep Applications and Pulse Oximeter
An observational clinical trial in a single centre. The objective of this study was to
 determine the efficacy of mandibular advancement device (MAD) therapy on snoring intensity,
 frequency, and oxygen desaturation periods in mild-moderate obstructive sleep apnea (OSA)
 patients with snoring problems. Totally, 18 mild-moderate OSA patients (8 females and 10
 males) with subjective snoring complaint were selected. Each patient's diagnostic
 polysomnographic analysis (PSG) was accepted as initial PSG values. Each patient was
 subjected simple pulse oximeter (SPO) and smartphone sleep application (SSA) at 3 different
 nights at home. Diagnostic mean values of oxygen desaturation index (obtained by using SPO),
 snoring intensity score (obtained by using SSA), and snoring percentage (obtained by using
 SSA) were recorded. Non-titratable-customized MAD with 60-75% of maximal mandibular
 protrusion were fabricated. The patients were instructed to wear their MAD every night. SPO
 and SSA measurement were repeated at the 1st, 4th, 12th, and 24th week of the treatment
 process. At the 24th week of treatment, The PSG were repeated and all PSG, SPO, and SSA
 values were compared with initial diagnostic values.
Inclusion Criteria:

 -  mild-moderate OSA patients with subjective snoring complaints

 Exclusion Criteria:

 -  Severe OSA

 -  Undergone previous surgical therapy for SS or OSA

 -  High-risk of cardiovascular, respiratory, neurological, or psychiatric disorders

 -  Inadequate dental anchor for MAD treatment

 -  Temporomandibular joint dysfunction

 -  Angle Class III maxillomandibular relation